Key statistics
On Tuesday, Coeptis Therapeutics Holdings Inc (COEP:NAQ) closed at 11.44, 82.75% above the 52 week low of 6.26 set on Apr 25, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 11.60 |
|---|---|
| High | 11.60 |
| Low | 11.16 |
| Bid | 11.80 |
| Offer | 12.70 |
| Previous close | 11.60 |
| Average volume | 29.63k |
|---|---|
| Shares outstanding | 5.76m |
| Free float | 4.91m |
| P/E (TTM) | -- |
| Market cap | 66.84m USD |
| EPS (TTM) | -3.47 USD |
Data delayed at least 15 minutes, as of Mar 03 2026 21:00 GMT.
More ▼
- Coeptis Receives Shareholder Approval Towards Z Squared Merger
- Coeptis Therapeutics S-4 Declared Effective by SEC, Proxy Mailing Begins in Anticipation of the Merger Transaction with Z Squared
- Coeptis (COEP) Extinguishes Convertible Note with YA II PN, Ltd
- Coeptis (COEP) Announces Filing of Registration Statement on Form S-4 with SEC in Connection with Proposed Transaction with Z Squared
- Monarch Therapeutics and SNAP Biosciences, Inc., a Subsidiary of Coeptis Therapeutics Holdings Inc., Enter Licensing Agreement to Bolster SNAP-CAR NK Cell Therapy in Oncology
- Coeptis Therapeutics, Inc. and Z Squared Inc. Announce Merger Agreement
- COEPTIS Partners with NexGenAI Solutions Group to Launch New AI Co-Working Hub in India, Driving Global Innovation in Technology
- Coeptis Therapeutics Secures Worldwide Development and Commercialization Rights to Next-Generation GEAR™ Cell Therapy Platform Strengthening its High-Impact Precision Immuno-Oncology Pipeline
- COEPTIS’ NexGenAI Affiliates Partners with NUBURU Network to Drive Innovation in AI and Robotics as Part of its Transformation Plan
More ▼
